Treatments for Anxiety and Insomnia
Drugs for Anxiety and Insomnia
Introduction to Drug Classes
Benzodiazepines: Primarily for short-term use due to dependence risks.
Antidepressants: Often used due to shared neurotransmitters and comorbidity with anxiety.
Miscellaneous Anxiolytics: Anti-anxiety medications.
Barbiturates: Rarely used due to significant risks.
Understanding Anxiety: Definitions and Disorders
Anxiety (Medical Diagnosis):
Emotional response or behavior in the presence of stress.
Distinguished from typical situational stress (e.g., exams, public speaking).
Defined when tension or apprehension is above and beyond expected levels.
May lack an identifiable trigger.
Requires a negative effect on quality of life or measurable inability to function normally to be a medical diagnosis/disorder.
Situational Anxiety:
Presents due to a temporary stressor or situation, with an identified trigger.
Examples: moving, loss, starting school.
Can sometimes be motivating or stimulating but can impair daily function.
Generalized Anxiety Disorder (GAD): Prolonged anxiety for at least 6 months, difficult to control.
Obsessive Compulsive Disorder (OCD):
Caused by intrusive thoughts leading to repetitive thoughts, possibly behaviors.
Impacts daily function (e.g., repetitive hand washing).
Diagnosis can exist with intrusive thoughts alone, without the overt behavior.
Phobias: Fears disproportional to typical or expected reactions.
Panic Attack:
Sudden episode of intense anxiety or fear.
Includes physical symptoms: chest pain, diaphoresis (sweating), shortness of breath, feeling faint, sensation of impending death.
No actual threat identified; not a normal response to actual danger.
Triggers the autonomic nervous system's ("ANS") fight-or-flight response, similar to actual danger.
Panic Disorder: Frequent or recurrent panic attacks, leading to fear of unexpected attacks.
Post-Traumatic Stress Disorder (PTSD):
Result of experiencing a traumatic event (single or prolonged).
Symptoms include physical body symptoms and reliving trauma through dissociations or flashbacks.
Like other disorders, it impairs daily life function.
Social Anxiety:
Increased or excessive anxiety in social settings, related to fear or discomfort of social interactions.
May involve excessive worry about being judged.
Agoraphobia: Irrational fear of specific situations or places (e.g., crowds).
Social anxiety and agoraphobia are distinct but not mutually exclusive.
Insomnia and Sleep Disorders
Rebound Insomnia:
Occurs when individuals stop using insomnia medications for sleep.
The resulting insomnia is worse than the initial insomnia that prompted medication use.
Increases anxiety.
Reason why sleep aids are not recommended for long-term use: medications override the inherent sleep drive, which is difficult to restore.
General Drug Types for Anxiety and Insomnia Symptoms
Anxiolytics: Drugs that help decrease anxiety.
Antidepressants: Often used because neurotransmitters involved in depression (Norepinephrine, Serotonin) are also linked to anxiety symptoms.
Sedatives: Depress central nervous system ("CNS") responses.
Hypnotics: Higher doses of sedatives used to induce sleep.
Sedative-Hypnotics: Can be used for both anxiety and sleep, especially for individuals whose sleep is negatively impacted by anxiety.
"Tranquilizer": An antiquated term, no longer common in medical context.
Limitations of Medications and Holistic Approaches
Medications for anxiety do not cure it; they decrease symptoms and improve function.
Holistic, Long-Term Approach: Understanding anxiety, identifying triggers, and developing healthy coping mechanisms.
This approach often combines pharmacologic and non-pharmacologic interventions, or non-pharmacologic strategies alone.
Non-Pharmacologic Strategies (Examples):
Cognitive Behavioral Therapy ("CBT").
Other counseling/psychotherapy techniques.
Biofeedback.
Meditation or mindfulness training and exercises.
Rationale for Pharmacologic Intervention:
When stress is overwhelming and outpaces coping ability, leading to anxiety symptoms.
Medication can reduce the overwhelm to allow individuals to learn and implement coping strategies (e.g., learning geometry amidst chaos analogy).
Used when anxiety level negatively impacts daily functioning.
Other Therapeutic Classes for Anxiety Symptoms
Antidepressants and CNS depressants (already discussed).
Anti-seizure medications: Sometimes used.
Anti-psychotic medications: Sometimes used.
Anti-hypertensive drugs & Anti-dysrhythmic medications: May be ordered (discussion reserved for cardiovascular section).
Herbal Preparations
Used to promote sleep and/or induce calm.
Examples: Melatonin, Valerian root, Kava.
Importance: Be aware of significant interactions with prescribed medications.
Melatonin Specifics:
Current studies suggest short-term use (
\le 3 months) is safe for adults.Analog prescription drugs should not be used concurrently.
Not approved for use in children.
Considered relatively safe in appropriate doses for children, but these are significantly lower than adult doses.
Not recommended for children under 5 years due to developing circadian rhythms; underlying cause of poor sleep in this age group is crucial to identify.
Connections: Anxiety, Insomnia, and Depression
Clear connection between anxiety and insomnia, and anxiety and depression.
"Chicken or the Egg" question: Does anxiety cause insomnia, or does lack of sleep cause anxiety?
Sleep Hygiene:
Should be evaluated before initiating any sleep medication.
Interventions (if indicated) should be implemented to promote better sleep routines before and during medication use to reduce reliance.
Techniques: Preparing for bed, no screen time (for at least 30 minutes, some suggest hours), darkening the room, creating a quiet and calm environment.
Over-the-Counter ("OTC") Sleep Medications:
Common for self-medication due to anxiety about lack of sleep.
Diphenhydramine (Benadryl):
Often induces drowsiness in adults.
Chronic use can lead to rebound insomnia.
Causes daytime drowsiness.
Not recommended for chronic use due to negative effects on wakefulness.
Pharmacologic Tidbit in Kids: Can cause a reverse (activating) effect; should not be used as a sleep aid in children.
Critical Pre-Medication Assessment for Sleep Disorders
Rule out underlying physiological conditions (e.g., sleep apnea) before initiating pharmacologic treatment, especially if medication further suppresses the CNS and could cause respiratory depression.
Failure to address core problems can lead to severe adverse effects.
Potential Assessments: Sleep study, Electroencephalogram ("EEG").
Specific Drug Classes and Prototype Drugs
Antidepressants
Comorbidity: High comorbidity between anxiety and depression (many with depression have anxiety, and vice-versa).
Neurotransmitter Theory: Same primary neurotransmitters (Norepinephrine, Serotonin) play a role.
Goal (Anxiety Treatment): Reduce overwhelm and negative thoughts, thereby reducing anxiety. Allows patients to learn skills to manage ANS (fight-or-flight) reactions.
Drug Classes:
Tricyclic Antidepressants ("TCAs").
Selective Serotonin Reuptake Inhibitors ("SSRIs").
Serotonin-Norepinephrine Reuptake Inhibitors ("SNRIs").
Monoamine Oxidase Inhibitors ("MAOIs").
Atypical Antipsychotics (less common for anxiety, but may be used in comorbidity).
Most Typical for GAD: The SSRI drug class.
Prototype SSRI: Lexapro (Escitalopram) or Citalopram (the transcript mentions Tala Prem for Lexapro; which is Citalopram, another SSRI).
Other Important SSRIs: Sertraline (Zoloft), Fluoxetine (Prozac).
Mechanism of action is generally similar across drugs in the same class.
Benzodiazepines
Prototype Drug: Lorazepam (Ativan).
Classification: Controlled drugs, Schedule IV.
Historical Use: Previously widely prescribed for anxiety and insomnia; now less so due to dependence issues.
Current Use: Limited to very short-term, situational use (e.g., intense phobia of flying).
Mechanism of Action: Enhance the effects of Gamma-aminobutyric acid ("GABA"), the most abundant inhibitory neurotransmitter, at its receptor sites.
Results in: sedating, relaxing, sleep-inducing, anxiety-reducing, and anticonvulsant effects.
Duration: Helpful for short-term use (up to 2 weeks).
Risks with Longer-Term/Chronic Use:
Dependence, tolerance, withdrawal symptoms.
Abrupt withdrawal from chronic use can lead to: seizures, delirium tremens, and even death.
Withdrawal from alcohol and benzodiazepines are two situations where withdrawal can be fatal.
Long-term users must be tapered off slowly.
Rare Adverse Effects:
Paradoxical Stimulation: Increased agitation or panic.
In Elderly Patients: Increased risk of short- and long-term adverse effects, paradoxical stimulation, aggression, suicidal ideation, and worsening dementia.
Considered inappropriate for elderly population due to decreased kidney/liver function affecting metabolism and memory issues.
Reversal Agent/Antidote: Flumazenil (a benzodiazepine antagonist).
Crucial to know antidotes.
Consider benzodiazepine's half-life: if longer than Flumazenil's, re-dosing of antidote and close monitoring are necessary.
Variations and Therapeutic Uses:
Same action and side effect profile, but onset and duration of action vary.
Lorazepam (Ativan): Pre-anesthetic agent, stopping status epilepticus, alcohol withdrawal (due to impact on GABA receptors, similar to alcohol).
Diazepam (Valium): Anticonvulsant properties, used for seizure disorders and status epilepticus.
Midazolam (Versed): Often for minor procedures, conscious to moderate sedation, pre-anesthetic. Causes inability to create memory (amnesia), which is why it exacerbates dementia in elderly.
Barbiturates
Current Use: Rarely used for anxiety or insomnia due to availability of safer options.
Primary Use: Anesthetic agents.
Not First or Second-Line: No longer a primary choice for anxiety or insomnia.
High Risks:
High risk of physical and psychological dependence.
Significantly depress the CNS at all levels.
Withdrawal is extreme and can be fatal.
Tolerance develops quickly.
Cross-tolerance with other CNS depressants (e.g., opioids).
Miscellaneous Anxiolytics / Insomnia-Specific Medications
Valproate (Depakote): An anti-seizure medication, sometimes used for anxiety.
Propranolol: A beta-blocker (beta-adrenergic antagonist), blocks the fight-or-flight response (referencing ANS lecture).
Insomnia-Specific Medications (e.g., "Z-drugs"):
Prototype: Zolpidem (Ambien).
Other Examples: Zaleplon (Sonata), Eszopiclone (Lunesta).
Current Use: Still used, but less frequently due to side effect profiles.
Rebound Insomnia: A significant problem with chronic use.
Administration: Must be taken when sleep is imminent due to a very short onset of action.
Safety Concerns: Patients may be active but not aware (
dissociated behaviors), leading to: sleepwalking, sleep-eating, sleep-driving.
Crucial patient education is required: take medication only when in bed and prepared to sleep (
20-30 minutes before).
Conclusion and Key Takeaways
Many medications for anxiety and insomnia have varied uses.
Be highly aware of side effects and safety concerns related to CNS depression.
Education is required to minimize dependence, especially for controlled substances.
Non-pharmacologic techniques should be:
Attempted initially for both anxiety (if overwhelm is manageable) and insomnia.
Considered as adjuncts to drug therapy in both situations.